1. health and fitness

Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth
by 2020
According to a new market report published by Persistence Market Research “Global
Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020,”
the global human insulin market was valued at USD 24,332.6 million in 2014 and
was expected to grow at a CAGR of 12.4% from 2014 to 2020, to reach an estimated
value of USD 49,197.3 million in 2020.
Globally, the human insulin market is witnessing significant growth due to increasing
prevalence of diabetes and increasing awareness among people about diabetes care.
In addition, technological advancements in insulin delivery devices and increasing
prevalence of lifestyle related disorders such as obesity are also driving the growth of
the market.
Request to view table of content @
https://www.persistencemarketresearch.com/toc/3308
However, uneven pricing and limited access to human insulin in emerging countries
such as Brazil, India, and China are inhibiting the growth of the human insulin
market. In addition, strict regulatory requirements for drug approval are also
restraining the growth of the market. The global human insulin market was
anticipated to grow from an estimated USD 24,332.6 million in 2014 to USD
49,197.3 million in 2020 at a CAGR of 12.4% during the forecast period.
In North America, increasing prevalence of diabetes with growing age and
availability of advanced human insulin infusion devices are driving the use of human
insulin in the market.
Request Sample Report @
https://www.persistencemarketresearch.com/samples/3308
In addition, increasing prevalence of lifestyle associated disorders such as obesity is
also boosting the growth of the human insulin market in this region. For instance,
according to the Centers for Diseases Control and Prevention (CDC), a U.S.-based
national public health institute, over one-third children and adolescents were obese in
2012 in the U.S.
In Europe, the human insulin market is driven by rising aging population and
increasing prevalence of diabetes. In addition, in Germany the market is evolving due
to rising prevalence of diabetes and increasing awareness among people about
diabetes care. However, in Asia-Pacific the growth for human insulin is much higher
than developed countries due to increasing prevalence of diabetes and increasing
government initiatives for improving healthcare.
Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, Tonghua Dongbao
Pharmaceutical Co., Ltd., Adocia, Merck & Co., Inc., Pfizer, Inc., Wockhardt,
Julphar, Bristol-Myers Squibb Company, GlaxoSmithKline Plc and Oramed
Pharmaceuticals, Inc. are some of the major players in human insulin market.
Buy Human Insulin Market Report @
https://www.persistencemarketresearch.com/checkout/3308
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com